GoodRx Holdings Inc (NASDAQ:GDRX) has a beta value of 1.45 and has seen 1.0 million shares traded in the last trading session. The company, currently valued at $2.60B, closed the last trade at $6.57 per share which meant it lost -$0.34 on the day or -4.92% during that session. The GDRX stock price is -42.62% off its 52-week high price of $9.37 and 36.99% above the 52-week low of $4.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.35 million shares traded. The 3-month trading volume is 1.70 million shares.
GoodRx Holdings Inc (NASDAQ:GDRX) trade information
Sporting -4.92% in the red in last session, the stock has traded in the red over the last five days, when the GDRX stock price touched $6.57 or saw a rise of 11.81%. Year-to-date, GoodRx Holdings Inc shares have moved -1.94%, while the 5-day performance has seen it change -10.61%. Over the past 30 days, the shares of GoodRx Holdings Inc (NASDAQ:GDRX) have changed -2.38%. Short interest in the company has seen 9.69 million shares shorted with days to cover at 6.49.
GoodRx Holdings Inc (GDRX) estimates and forecasts
Figures show that GoodRx Holdings Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 9.50% over the past 6 months, with this year growth rate of 42.86%, compared to 13.20% for the industry. Revenue growth from the last financial year stood is estimated to be 6.70%.
16 analysts offering their estimates for the company have set an average revenue estimate of $196.01 million for the current quarter. 16 have an estimated revenue figure of $199.61 million for the next quarter concluding in Jun 2024. Year-ago sales stood $183.99 million and $189.68 million respectively for this quarter and the next, and analysts expect sales will grow by 6.50% for the current quarter and 5.20% for the next.
Earnings growth for 2024 is a modest 26.90% while over the next 5 years, the company’s earnings are expected to increase by 21.20%.
GDRX Dividends
GoodRx Holdings Inc is expected to release its next earnings report between May 08 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GoodRx Holdings Inc (NASDAQ:GDRX)’s Major holders
Insiders own 11.89% of the company shares, while shares held by institutions stand at 61.60% with a share float percentage of 69.91%. Investors are also buoyed by the number of investors in a company, with GoodRx Holdings Inc having a total of 185 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 8.5 million shares worth more than $46.94 million. As of Jun 29, 2023, Vanguard Group Inc held 10.11% of shares outstanding.
The other major institutional holder is Silver Lake Group, LLC, with the holding of over 3.53 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $19.5 million and represent 4.20% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. As of Jun 29, 2023, the former fund manager holds about 2.77% shares in the company for having 2.33 million shares of worth $12.88 million while later fund manager owns 1.82 million shares of worth $10.07 million as of Jun 29, 2023, which makes it owner of about 2.17% of company’s outstanding stock.
